Update on Medication Use Quality and Safety in Older Adults, 2017.

Shelly L Gray, Zachary A Marcum, Kenneth E Schmader, Joseph T Hanlon
Author Information
  1. Shelly L Gray: Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington.
  2. Zachary A Marcum: Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington.
  3. Kenneth E Schmader: Division of Geriatrics, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, North Carolina.
  4. Joseph T Hanlon: Division of Geriatrics, Department of Medicine, School of Medicine, Pittsburgh, Pennsylvania.

Abstract

Improving the quality of medication use and medication safety in older adults is an important public health priority and is of paramount importance for clinicians who care for them. We selected four important articles from 2017 that address these issues to annotate and critique, and we discuss the broader implications for optimizing medication use. A longer list of articles is given in an online appendix. The first study provides national data on the prevalence of central nervous system-active medication polypharmacy in older adults and how this has changed over a 9-year period (2004-2013). The second study characterizes prevalence of and factors associated with nonadherence to antiepileptic drugs in 36,912 older adults with epilepsy, with an emphasis on minorities. The third study describes the extent of antibiotic use in residents of 381 long-term care facilities (LTCF) in British Columbia, Canada, from 2007 to 2014. Finally, we discuss a meta-analysis of 42 studies that evaluated the prevalence of hospital admissions caused by adverse drug reactions in older adults. This article is intended to provide a narrative review of important publications on medication use quality and safety for clinicians and researchers committed to optimizing medication use in older adults. J Am Geriatr Soc 66:2254-2258, 2018.

Keywords

References

  1. Clin Interv Aging. 2014 Dec 01;9:2079-86 [PMID: 25489239]
  2. J Am Geriatr Soc. 2015 Nov;63(11):2227-46 [PMID: 26446832]
  3. Arch Intern Med. 2011 Mar 14;171(5):438-43 [PMID: 21403040]
  4. Am J Geriatr Pharmacother. 2011 Feb;9(1):11-23 [PMID: 21459305]
  5. Age Ageing. 2015 Mar;44(2):213-8 [PMID: 25324330]
  6. BMC Geriatr. 2012 Nov 23;12:73 [PMID: 23176555]
  7. Epilepsy Behav. 2012 Nov;25(3):297-302 [PMID: 23099230]
  8. Epilepsy Behav. 2017 Jan;66:68-73 [PMID: 28038389]
  9. J Gerontol A Biol Sci Med Sci. 2009 Apr;64(4):492-8 [PMID: 19196642]
  10. JAMA. 2016 Nov 22;316(20):2115-2125 [PMID: 27893129]
  11. J Am Geriatr Soc. 2009 Feb;57(2):243-50 [PMID: 19207141]
  12. Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):916-22 [PMID: 19585466]
  13. Eur J Clin Pharmacol. 2017 Jun;73(6):759-770 [PMID: 28251277]
  14. J Am Geriatr Soc. 2018 Feb;66(2):282-288 [PMID: 29265170]
  15. J Clin Psychiatry. 2017 Apr;78(4):e363-e371 [PMID: 28448697]
  16. Ann Pharmacother. 2008 Jul;42(7):1017-25 [PMID: 18594048]
  17. PLoS Med. 2017 Oct 3;14(10):e1002396 [PMID: 28972983]
  18. J Am Geriatr Soc. 2017 Sep;65(9):2052-2056 [PMID: 28467623]
  19. Clin Geriatr Med. 2018 Feb;34(1):39-54 [PMID: 29129216]
  20. J Am Geriatr Soc. 2015 Dec;63(12):e8-e18 [PMID: 26447889]
  21. Neurology. 2014 Nov 25;83(22):2085-90 [PMID: 25355825]
  22. J Am Med Dir Assoc. 2017 Dec 1;18(12):1098.e1-1098.e11 [PMID: 29169741]
  23. JAMA Intern Med. 2017 Apr 1;177(4):583-585 [PMID: 28192559]

Grants

  1. K12 HS022982/AHRQ HHS
  2. P30 AG024827/NIA NIH HHS
  3. P30AG028716/NIA, Duke Pepper Older Americans Independence Center
  4. Z01 AG000678/Intramural NIH HHS
  5. /Agency for Health Research and Quality
  6. U01AG00678/National Institute on Aging (NIA), National Institutes of Health
  7. K12HS022982/Agency for Healthcare Research and Quality
  8. P30AG024827/NIA NIH HHS
  9. IIR 14-306/Veterans Affairs Health Services Research and Development Service Merit Awards
  10. P30 AG028716/NIA NIH HHS
  11. IIR 15-115/Veterans Affairs Health Services Research and Development Service Merit Awards
  12. R18 HS023779/AHRQ HHS

MeSH Term

Aged
British Columbia
Deprescriptions
Drug Prescriptions
Drug-Related Side Effects and Adverse Reactions
Hospitalization
Humans
Inappropriate Prescribing
Medication Adherence
Patient Safety
Polypharmacy

Word Cloud

Created with Highcharts 10.0.0medicationuseolderadultsimportantstudyprevalencequalitysafetyclinicianscarearticles2017discussoptimizingpolypharmacyadversedrugImprovingpublichealthpriorityparamountimportanceselectedfouraddressissuesannotatecritiquebroaderimplicationslongerlistgivenonlineappendixfirstprovidesnationaldatacentralnervoussystem-activechanged9-yearperiod2004-2013secondcharacterizesfactorsassociatednonadherenceantiepilepticdrugs36912epilepsyemphasisminoritiesthirddescribesextentantibioticresidents381long-termfacilitiesLTCFBritishColumbiaCanada20072014Finallymeta-analysis42studiesevaluatedhospitaladmissionscausedreactionsarticleintendedprovidenarrativereviewpublicationsresearcherscommittedJGeriatrSoc66:2254-22582018UpdateMedicationUseQualitySafetyOlderAdultseventsdrug-relatedproblemsinappropriateprescribing

Similar Articles

Cited By (5)